Year: 2024
Type: editorial
Abstract: The autologous T-cell therapy ACTengine IMA203 (Immatics) demonstrated tolerability and 88% tumor shrinkage rate in 26 patients with heavily pretreated metastatic melanoma enrolled in a Phase 1b tr...
Authors: Ronald Ellis, Adam Weiss
Institution: Taylor and Francis (United Kingdom)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,175
OpenAlex ID: W4404473507